Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Use of CereGate Therapy for Freezing of Gait in PD

NCT: NCT05292794 · RECRUITING

NCT IDNCT05292794
StatusRECRUITING
Start Date2022-04-18
Completion2027-07

Brief Summary

A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease.

Frequently Asked Questions

What is Use of CereGate Therapy for Freezing of Gait in PD?

Use of CereGate Therapy for Freezing of Gait in PD is a clinical trial registered under NCT05292794. Current status: RECRUITING.

What is the status of NCT05292794?

The current status of NCT05292794 (Use of CereGate Therapy for Freezing of Gait in PD) is: RECRUITING.

When did Use of CereGate Therapy for Freezing of Gait in PD start?

Use of CereGate Therapy for Freezing of Gait in PD started on 2022-04-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.